| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.24 | 2e-07 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |